Neurofilament light chain (NfL) has been identified as reliable fluid biomarker for neuroaxonal damage in neurodegenerative diseases [17], with first studies showing higher NfL levels in MSA compared to PD [18, 19]. The gene discussed is NEFL; the disease is multiple system atrophy.